SPAC Warrant
A warrant on a blank-check company — worthless if no deal closes, callable by the company if the deal works.
A SPAC warrant is a redeemable warrant issued as part of the IPO unit, conventionally exercisable at $11.50 per share, five years from the closing of a business combination. Before a deal closes it is an option on an option: it has no exercisable underlying, and it expires worthless if the SPAC liquidates. After a deal closes, the company can force redemption once the stock trades above a threshold, which caps the warrant's life.
In detail
The public SPAC warrant is the most standardized warrant in the market and still not standard. The conventional terms — $11.50 exercise, exercisable 30 days after the business combination or 12 months after the IPO, whichever is later, expiring five years after the combination, redeemable at $0.01 if the common trades at or above $18.00 for 20 of 30 trading days — recur across hundreds of deals, but each is set in that SPAC's own warrant agreement, and variations are common and material.
Warrants come to exist in the IPO as a component of the unit, registered on the S-1, with the warrant agreement between the company and the warrant agent filed as an exhibit. A parallel class of private placement warrants is sold to the sponsor at the same time on different terms — typically not redeemable while held by the sponsor, exercisable on a cashless basis, and subject to transfer restrictions — and those terms are in the same agreement.
A holder owns a contractual right against the company. Before the combination, the underlying does not meaningfully exist: the warrant is a claim on the equity of a business the SPAC has not yet acquired. If the SPAC liquidates, public shares are redeemed at trust and warrants receive nothing. This asymmetry is the defining fact of the instrument.
After a combination closes, the warrant becomes an ordinary company warrant with two dominant terms. The redemption trigger lets the company call the warrants for a nominal amount once the stock clears the threshold, forcing holders to exercise or lose the position — which is why a warrant's value compresses toward intrinsic as the stock approaches the trigger. Some agreements add an alternative redemption at $10.00 with a make-whole table permitting cashless settlement in a smaller number of shares. Exercisability also depends on an effective registration statement covering the underlying shares; where none is effective, the agreement typically permits cashless exercise, and where neither is available, the warrant is temporarily unexercisable. Warrant agreements can be amended with the consent of a stated percentage of holders — commonly 50% or 65% — which is how warrants get exchanged, repriced, or cashed out in a deal.
Lifecycle events: warrant agreement as an exhibit to the IPO 8-K; commencement of exercisability announced in 8-K; the business combination's treatment of warrants in the S-4; redemption calls in 8-K and a formal notice with a fixed deadline; amendments approved by consent solicitation; expiration five years after closing; delisting where the post-deal company fails exchange standards; and worthless expiry on SPAC liquidation.
Before assuming anything, read that SPAC's warrant agreement; check whether exercisability has been triggered and whether a registration statement is effective; find the redemption threshold and how close the common is to it; and, pre-deal, recognize the instrument for what it is — a contingent claim that pays nothing if the deadline passes.
These values are read from the filing linked above. They describe the instrument, not its merits. Nothing here is investment advice.